BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31805288)

  • 1. Human p21-activated kinase 5 (PAK5) expression and potential mechanisms in relevant cancers: Basic and clinical perspectives for molecular cancer therapeutics.
    Li YK; Zou J; Ye DM; Zeng Y; Chen CY; Luo GF; Zeng X
    Life Sci; 2020 Jan; 241():117113. PubMed ID: 31805288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAK5 Induces EMT and Promotes Cell Migration and Invasion by Activating the PI3K/AKT Pathway in Ovarian Cancer.
    Li D; Pan Y; Huang Y; Zhang P; Fang X
    Anal Cell Pathol (Amst); 2018; 2018():8073124. PubMed ID: 30245957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An oncogenic kinase: putting PAK5 forward.
    Wen YY; Zheng JN; Pei DS
    Expert Opin Ther Targets; 2014 Jul; 18(7):807-15. PubMed ID: 24869804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAK5 promotes the migration and invasion of cervical cancer cells by phosphorylating SATB1.
    Huo FC; Pan YJ; Li TT; Mou J; Pei DS
    Cell Death Differ; 2019 Jun; 26(6):994-1006. PubMed ID: 30082769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-129 suppresses tumor cell growth and invasion by targeting PAK5 in hepatocellular carcinoma.
    Zhai J; Qu S; Li X; Zhong J; Chen X; Qu Z; Wu D
    Biochem Biophys Res Commun; 2015 Aug; 464(1):161-7. PubMed ID: 26116538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P21-activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migration.
    Gong W; An Z; Wang Y; Pan X; Fang W; Jiang B; Zhang H
    Int J Cancer; 2009 Aug; 125(3):548-55. PubMed ID: 19415746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAK5-mediated phosphorylation and nuclear translocation of NF-κB-p65 promotes breast cancer cell proliferation in vitro and in vivo.
    Zhang YC; Huo FC; Wei LL; Gong CC; Pan YJ; Mou J; Pei DS
    J Exp Clin Cancer Res; 2017 Oct; 36(1):146. PubMed ID: 29041983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of PAK5 inhibits glioma cell migration and invasion potentially through the PAK5-Egr1-MMP2 signaling pathway.
    Han ZX; Wang XX; Zhang SN; Wu JX; Qian HY; Wen YY; Tian H; Pei DS; Zheng JN
    Brain Tumor Pathol; 2014 Oct; 31(4):234-41. PubMed ID: 24062079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAK5 is auto-activated by a central domain that promotes kinase oligomerization.
    Tabanifar B; Zhao Z; Manser E
    Biochem J; 2016 Jun; 473(12):1777-89. PubMed ID: 27095851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The overexpression of P21-activated kinase 5 (PAK5) promotes paclitaxel-chemoresistance of epithelial ovarian cancer.
    Li D; Yao X; Zhang P
    Mol Cell Biochem; 2013 Nov; 383(1-2):191-9. PubMed ID: 23877225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAK5 facilitates the proliferation, invasion and migration in colorectal cancer cells.
    Huang S; Zhu Y; Wang C; Li X; Cui X; Tu S; You L; Fu J; Chen Z; Hu W; Gong W
    Cancer Med; 2020 Jul; 9(13):4777-4790. PubMed ID: 32383357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning and characterization of PAK5, a novel member of mammalian p21-activated kinase-II subfamily that is predominantly expressed in brain.
    Pandey A; Dan I; Kristiansen TZ; Watanabe NM; Voldby J; Kajikawa E; Khosravi-Far R; Blagoev B; Mann M
    Oncogene; 2002 May; 21(24):3939-48. PubMed ID: 12032833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAK5-Egr1-MMP2 signaling controls the migration and invasion in breast cancer cell.
    Wang XX; Cheng Q; Zhang SN; Qian HY; Wu JX; Tian H; Pei DS; Zheng JN
    Tumour Biol; 2013 Oct; 34(5):2721-9. PubMed ID: 23696025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p21-activated kinase 5 inhibits camptothecin-induced apoptosis in colorectal carcinoma cells.
    Wang X; Gong W; Qing H; Geng Y; Wang X; Zhang Y; Peng L; Zhang H; Jiang B
    Tumour Biol; 2010 Dec; 31(6):575-82. PubMed ID: 20567954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAK5 mediates cell: cell adhesion integrity via interaction with E-cadherin in bladder cancer cells.
    Ismail AF; Oskay Halacli S; Babteen N; De Piano M; Martin TA; Jiang WG; Khan MS; Dasgupta P; Wells CM
    Biochem J; 2017 Mar; 474(8):1333-1346. PubMed ID: 28232500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21-Activated kinase 5: a pleiotropic kinase.
    Wen YY; Wang XX; Pei DS; Zheng JN
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6636-9. PubMed ID: 24215894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer.
    Zhu G; Li X; Guo B; Ke Q; Dong M; Li F
    Oncogene; 2016 Apr; 35(15):1943-54. PubMed ID: 26212009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAK5-mediated AIF phosphorylation inhibits its nuclear translocation and promotes breast cancer tumorigenesis.
    Xing Y; Li Y; Hu B; Han F; Zhao X; Zhang H; Li Y; Li D; Li J; Jin F; Li F
    Int J Biol Sci; 2021; 17(5):1315-1327. PubMed ID: 33867848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR‑489 promotes apoptosis and inhibits invasiveness of glioma cells by targeting PAK5/RAF1 signaling pathways.
    Wang W; Zhang L; Gao W; Zhang D; Zhao Z; Bao Y
    Oncol Rep; 2019 Dec; 42(6):2390-2401. PubMed ID: 31638257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAK5 promotes RNA helicase DDX5 sumoylation and miRNA-10b processing in a kinase-dependent manner in breast cancer.
    Li Y; Xing Y; Wang X; Hu B; Zhao X; Zhang H; Han F; Geng N; Wang F; Li Y; Li J; Jin F; Li F
    Cell Rep; 2021 Dec; 37(12):110127. PubMed ID: 34936874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.